Biogen Lithuania - Company finances
|
EUR
|
2020
From: 2020-06-22
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 365,277 | 808,872 | 968,253 | 812,899 | 589,086 | 390,638 |
| Profit before tax | 20,167 | 35,588 | 42,393 | 38,795 | 28,067 | 18,920 |
| Net profit | 3,337 | 32,194 | 23,950 | 27,273 | 24,934 | 13,712 |
| Equity | 3,337 | 38,031 | 61,981 | 89,254 | 114,188 | 127,900 |
| Liabilities | 28,364 | 50,507 | 49,733 | 52,094 | 526,189 | 128,705 |
| Non-current assets | 13,430 | 17,193 | 11,656 | 13,189 | 13,376 | 6,734 |
| Current assets | 314,514 | 159,210 | 245,819 | 190,764 | 703,931 | 262,385 |
| Total assets | 327,944 | 176,403 | 257,475 | 203,953 | 717,307 | 269,119 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 98,346 | 48,375 | 55,790 |
| Social insurance contributions | - | - | - | 109,394 | - | - |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +121.4% | +19.7% | -16.0% | -27.5% | -33.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.0% | 18.3% | 9.3% | 13.4% | 3.5% | 5.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 84.7% | 38.6% | 30.6% | 21.8% | 10.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.9% | 4.0% | 2.5% | 3.4% | 4.2% | 3.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.5% | 4.4% | 4.4% | 4.8% | 4.8% | 4.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 8.5 | 1.3 | 0.8 | 0.6 | 4.6 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 213,076 | 115,553 | 154,920 | 152,420 | 196,362 | 223,222 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biogen Lithuania - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-12-16 | 2025-12-18 | 325.61 |
| 2025-01-16 | 2025-01-16 | 2458.89 |
| 2024-12-17 | 2024-12-20 | 1587.85 |
| 2024-11-18 | 2024-11-21 | 2950.37 |
| 2022-08-23 | 2022-09-13 | 21.29 |
| 2021-09-16 | 2021-09-29 | 0.29 |
Biogen Lithuania - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biogen Lithuania, UAB (code 305577507) is a Private Limited Liability Company engaged in activities of head offices. In the latest financial year, 2025, the company generated revenue of €390.6K and net profit of €13.7K, corresponding to a profit margin of 3.5%. Revenue declined by 33.7% year on year and by 52.0% compared with 2023, moving from €812.9K in 2023 to €589.1K in 2024 and then to €390.6K in 2025. Net profit followed a softer downward trend, from €27.3K in 2023 to €24.9K in 2024 and €13.7K in 2025, while margins remained relatively stable in the 3.4% to 4.2% range. The balance sheet changed materially in 2025: total assets were €269.1K, equity €127.9K and liabilities €128.7K, after a much larger asset base in 2024. Key ratios for 2025 include ROE of 10.7%, ROA of 5.1%, debt-to-equity of 1.01 and asset turnover of 1.45x. Reported revenue per employee was €390.6K, with profit per employee of €13.7K.